Journal
EXPERT OPINION ON DRUG DISCOVERY
Volume 14, Issue 5, Pages 455-468Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/17460441.2019.1588880
Keywords
Antimicrobials; antimicrobial resistance mechanisms; novel antimicrobials; genomics; transcriptomics; proteomics; metabolomics
Categories
Funding
- Russian Foundation for Basic Research [18-04-00660]
Ask authors/readers for more resources
Introduction: The development of new antimicrobials has become an urgent priority because of a global challenge emerging from the rise of antimicrobial resistant pathogens. Areas covered: In this review, the authors discuss the opportunities offered by modern omics approaches to address the challenge and the use of this approach in antimicrobial development. Specifically, the authors focus on the role of omics technologies and bioinformatics for the revelation of the effects of antimicrobials in a variety of microbial cellular processes, as well as the identification of potential cellular targets, the mechanisms of antimicrobial resistance, and the development of new antimicrobials. Expert opinion: Prevention of antimicrobial resistance does not only depend on rational drug design such as narrow-spectrum antimicrobials but on several factors. It is the opinion of the authors that the use of a multi-omics bioinformatics approach should become an integral part of antimicrobial drug discovery as well as in the prevention of antimicrobial resistance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available